David Hallal
Chief Executive Officer at Scholar Rock Holding; Director at Seer; Director at Kalaris Therapeutics. Based in Cambridge, Massachusetts.
- Rank
- 1578th of 14,644
- Companies held
- 3
- Largest holding
- SRRK, 99.0% of total
- Latest SEC filing
- Sep 21, 2026
What the $93.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Scholar Rock Holding SRRK Common Stock | Directly | 1,602,382 | $50.37 | $80.7M | 86.0% | Form 4, Sep 21, 2026 |
| Scholar Rock Holding SRRK Common Stock | Through The Hallal Family Irrevocable Trust - 2012 | 205,000 | $50.37 | $10.3M | 11.0% | Form 4, Sep 21, 2026 |
| Scholar Rock Holding SRRK Common Stock | Through The Hallal Family Irrevocable Trust - 2021 | 36,652 | $50.37 | $1.8M | 2.0% | Form 4, Sep 21, 2026 |
| Seer SEER Class A Common Stock | Directly | 355,128 | $1.39 | $492K | 0.5% | Form 4, Jun 12, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Shares held by ElevateBio LLC Reported jointly by 4 insiders; split evenly | 181,247 split-adjusted | $1.35 | $245K | 0.3% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Directly | 93,203 split-adjusted | $1.35 | $126K | 0.1% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Shares held by The Hallal Family Irrevocable Trust 2012 | 31,346 split-adjusted | $1.35 | $42K | 0.0% | Form 4, Jun 6, 2024 |
| Kalaris Therapeutics KLRS Common Stock | Shares held by Terrie A. Hallal Family Irrevocable Trust 2012 | 6,007 split-adjusted | $1.35 | $8K | 0.0% | Form 4, Jun 6, 2024 |
Share counts are the amounts David Hallal reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1575 | Therese Tucker Director, BlackLine. Woodland Hills, CA | $94.0M |
| 1576 | John Radziwill Chairman of the Board, StoneX Group. New York, NY | $93.9M |
| 1577 | Yanjun Wang CCO and GC, Sea | $93.8M |
| 1578 | David Hallal Chief Executive Officer, Scholar Rock Holding. Cambridge, MA | $93.8M |
| 1579 | Jason Klein Director, Paymentus Holdings. Menlo Park, CA | $93.3M |
| 1580 | Mollie H. Carter Executive Chair, FirstSun Capital Bancorp. Denver, CO | $93.3M |
| 1581 | Andreas von Blottnitz Director, AppFolio. Santa Barbara, CA | $93.3M |
Other Scholar Rock Holding insiders
All SRRK insiders- Akshay Vaishnaw$31.8MPresident of R&D. #3318 overall
- Keith Woods$31.2MChief Operating Officer. #3662 overall
- Vikas Sinha$31.2MChief Financial Officer. #3539 overall
- Nagesh K. Mahanthappa$24.2MInterim CEO and President. #4489 overall
- Jay Backstrom$21.4MCHIEF EXECUTIVE OFFICER. #4912 overall
- Yung H. Chyung$13.0MChief Medical Officer. #6992 overall
Questions
How much stock does David Hallal own?
David Hallal holds $93,796,779 in listed stock based on SEC filings and current prices, mostly Scholar Rock Holding (SRRK). That ranks 1578th on the Stock Rich List.
Is this David Hallal's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did David Hallal last buy or sell stock?
The most recent open-market trade on file is a sale of 30,615 SRRK shares on Apr 16, 2026 at $49.57.